Hypercholesteremic patients have elevated ET-1 serum and tissue levels, while vascular ET-1 system activity is enhanced in patients with obesity, metabolic syndrome or diabetes mellitus type 2, which has been shown in several studies [20,21,22,23]. This evidence concerns the gene EDN1 and Obesity.